| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2020.07.066 |
| P698 | PubMed publication ID | 32773242 |
| P2093 | author name string | Benjamin Y Klein | |
| P2860 | cites work | Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes | Q21134119 |
| Immunometabolic circuits in trained immunity | Q28066501 | ||
| Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review | Q30244615 | ||
| Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends | Q31473026 | ||
| Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study | Q33877521 | ||
| Incidence and trend of type 1 diabetes and the underlying environmental determinants | Q91397679 | ||
| New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia | Q91508628 | ||
| Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms | Q91711356 | ||
| Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies | Q92870080 | ||
| Neonatal BCG vaccination reduces interferon gamma responsiveness to heterologous pathogens in infants from a randomised controlled trial | Q92992000 | ||
| CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes | Q93163082 | ||
| Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes | Q96126181 | ||
| Prevention of type I diabetes in NOD mice by adjuvant immunotherapy | Q34170075 | ||
| Hygiene hypothesis and autoimmune diseases | Q34233260 | ||
| Effect of adjuvant therapy on development of diabetes in mouse and man. | Q34322136 | ||
| Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes | Q34414098 | ||
| Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada | Q34424713 | ||
| The BCG World Atlas: a database of global BCG vaccination policies and practices | Q34708175 | ||
| CD4 T cells: fates, functions, and faults | Q34813153 | ||
| Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. | Q35740373 | ||
| Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells | Q35996475 | ||
| Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes | Q36576134 | ||
| BCG-induced trained immunity in NK cells: Role for non-specific protection to infection | Q37374103 | ||
| Microbial 'Old Friends', immunoregulation and stress resilience. | Q37404284 | ||
| Hygiene and the world distribution of Alzheimer's disease: Epidemiological evidence for a relationship between microbial environment and age-adjusted disease burden | Q37404439 | ||
| Immunometabolic Pathways in BCG-Induced Trained Immunity | Q37525436 | ||
| Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity | Q37620298 | ||
| TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment. | Q38607412 | ||
| Polyneuritis following BCG re-vaccination | Q39119768 | ||
| Role of reactive oxygen species (ROS) in Mycobacterium bovis bacillus Calmette Guérin-mediated up-regulation of the human cathelicidin LL-37 in A549 cells | Q39803932 | ||
| Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin | Q39968181 | ||
| The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989 | Q41116751 | ||
| Generalized lymphadenitis following B.C.G. vaccination in an immunocompetent 12-year-old boy. | Q43824784 | ||
| Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. II. Suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice | Q44163766 | ||
| Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells | Q44368031 | ||
| BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity | Q47555324 | ||
| Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. | Q50787251 | ||
| Ethnic differences in the incidence of childhood IDDM in Israel (1965-1993). Marked increase since 1985, especially in Yemenite Jews. | Q50962990 | ||
| The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. | Q55063493 | ||
| Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. | Q55290300 | ||
| Androgen-Induced Immunosuppression. | Q55357541 | ||
| 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis | Q55933791 | ||
| Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life | Q57175032 | ||
| Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon War | Q57796369 | ||
| Sex Hormones in Acquired Immunity and Autoimmune Disease | Q58583865 | ||
| Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse | Q63965633 | ||
| Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination | Q68716025 | ||
| Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant | Q70271788 | ||
| BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice | Q72409805 | ||
| BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide | Q73501296 | ||
| BCG Therapy for Type 1 Diabetes: Restoration of Balanced Immunity and Metabolism | Q90842175 | ||
| Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients | Q91164406 | ||
| Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age | Q91185699 | ||
| P921 | main subject | BCG vaccine | Q798309 |
| P577 | publication date | 2020-08-06 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone |
Search more.